Yayınlar & Eserler

Yayın Ağı
Makaleler 69
Tümü (69)
SCI-E, SSCI, AHCI (57)
SCI-E, SSCI, AHCI, ESCI (62)
Scopus (69)
TRDizin (8)

1. Peritonitis due to brucellosis in a patient newly diagnosed with liver cirrhosis complicated by ascites: A case report and literature review

Ekici R., Filiz M., Onus S., Akcay A. G., Bakir T., Buyukturan G., et al.
Hepatology Forum , cilt.7, sa.2, ss.167-170, 2026 (Scopus)

2. New classification of drug induced liver injury (DILI) in AASLD guidance: What is next?

ERÇİN C. N.
Hepatology Forum , cilt.5, sa.2, ss.61-62, 2024 (Scopus, TRDizin)

3. The relationship of atherogenic index of plasma with endothelial dysfunction biomarkers in patients with metabolic associated fatty liver disease

Kırık A., Gürel H., Genç H., Çelebi G., Yekdeş A. C., Tapan S., et al.
Gulhane Medical Journal , cilt.64, sa.3, ss.240-247, 2022 (Scopus, TRDizin)

4. Yttrium-90 (Y-90) resin microsphere therapy for patients with unresectable hepatocellular carcinoma. Identification of successful treatment response predictors and patient selection

ARSLAN N., İNCE S., OKUYUCU K., ŞAN H., ALAGÖZ E., KARADURMUŞ N., et al.
Annali Italiani di Chirurgia , cilt.92, sa.6, ss.623-631, 2021 (SCI-Expanded, Scopus)

5. Betatrophin levels are related to the early histological findings in nonalcoholic fatty liver disease

Sonmez A., Dogru T., ERÇİN C. N., Genc H., Celebi G., Gurel H., et al.
Metabolites , cilt.11, sa.7, 2021 (SCI-Expanded, Scopus) Creative Commons License

6. Microvesicular steatosis: A missed item in the management of nonalcoholic fatty liver disease?

Celebi G., Cicek A., Gurel H., Genc H., Kirik A., ERÇİN C. N., et al.
Acta Gastro-Enterologica Belgica , cilt.83, sa.4, ss.565-570, 2020 (SCI-Expanded, Scopus)

7. The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists

Kabaçam G., DAYANGAÇ M., Üçbilek E., ERÇİN C. N., Günsar F., Akyıldız M., et al.
Turkish Journal of Gastroenterology , cilt.31, sa.5, ss.348-355, 2020 (SCI-Expanded, Scopus, TRDizin)

8. Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience

İNCE S., Karaman B., ALAGÖZ E., KARADURMUŞ N., Şan H., ERÇİN C. N., et al.
Journal of gastrointestinal cancer , cilt.48, sa.3, ss.281, 2017 (Scopus)

9. Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease

Gurel H., Genc H., Celebi G., SERTOĞLU E., Cicek A., KAYADİBİ H., et al.
European review for medical and pharmacological sciences , cilt.20, sa.20, ss.4305-4312, 2016 (SCI-Expanded, Scopus)

10. The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with non-alcoholic fatty liver disease

ERÇİN C. N., Doğru T., Çelebi G., Gürel H., Genç H., SERTOĞLU E., et al.
Turkish Journal of Medical Sciences , cilt.46, sa.4, ss.985-991, 2016 (SCI-Expanded, Scopus, TRDizin)

11. Uric acid in nonalcoholic fatty liver disease

ERÇİN C. N., Gurel H., Dogru T.
European Journal of Gastroenterology and Hepatology , cilt.28, sa.5, ss.609-610, 2016 (SCI-Expanded, Scopus)

12. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease

Kara M., Dogru T., Genc H., SERTOĞLU E., Celebi G., Gurel H., et al.
European Journal of Gastroenterology and Hepatology , cilt.27, sa.10, ss.1144-1148, 2015 (SCI-Expanded, Scopus)

13. Insulin resistance but not visceral adiposity index is associated with liver fibrosis in nondiabetic subjects with nonalcoholic fatty liver disease

ERÇİN C. N., Dogru T., Genc H., Celebi G., Aslan F., Gurel H., et al.
Metabolic Syndrome and Related Disorders , cilt.13, sa.7, ss.319-325, 2015 (SCI-Expanded, Scopus)

14. Value of fetuin-A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease

SERTOĞLU E., Dogru T., ERÇİN C. N.
Liver International , cilt.35, sa.8, ss.2061, 2015 (SCI-Expanded, Scopus)

15. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

Sonmez A., Nikolic D., Dogru T., ERÇİN C. N., Genc H., Cesur M., et al.
Journal of Clinical Lipidology , cilt.9, sa.4, ss.576-582, 2015 (SCI-Expanded, Scopus)

16. The relationship of circulating Fetuin-A with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease

Celebi G., Genc H., Gurel H., SERTOĞLU E., Kara M., Tapan S., et al.
Saudi Journal of Gastroenterology , cilt.21, sa.3, ss.139-145, 2015 (SCI-Expanded, Scopus)

17. Neutrophil-to-lymphocyte ratio as a predictor of fibrosis in inactive hepatitis B carriers

ERÇİN C. N., Dogru T., SERTOĞLU E.
European Journal of Gastroenterology and Hepatology , cilt.27, sa.4, ss.475-476, 2015 (SCI-Expanded, Scopus)

18. Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease

Dogru T., SERTOĞLU E., Celebi G., Gurel H., ERÇİN C. N.
Upsala Journal of Medical Sciences , cilt.119, sa.1, ss.58-59, 2014 (SCI-Expanded, Scopus)

19. The relationship of serum uric acid with non-alcoholic fatty liver disease

SERTOĞLU E., ERÇİN C. N., Celebi G., Gurel H., KAYADİBİ H., Genc H., et al.
Clinical Biochemistry , cilt.47, sa.6, ss.383-388, 2014 (SCI-Expanded, Scopus)

20. Carotid atherosclerosis or nonalcoholic fatty liver disease: Which comes first?

Dogru T., Genc H., ERÇİN C. N.
Atherosclerosis , cilt.231, sa.2, ss.187-188, 2013 (SCI-Expanded, Scopus)

21. Alpha fetoprotein levels and its relationship with histopathological findings in patients with non-alcoholic fatty liver disease

Kara M., Genc H., Tapan S., Meral C., ERÇİN C. N., Erdal M., et al.
European Review for Medical and Pharmacological Sciences , cilt.17, sa.11, ss.1536-1541, 2013 (SCI-Expanded, Scopus)

22. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease

Dogru T., Genc H., Tapan S., Aslan F., ERÇİN C. N., Ors F., et al.
Clinical Endocrinology , cilt.78, sa.5, ss.712-717, 2013 (SCI-Expanded, Scopus)

23. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease

Genc H., Dogru T., Kara M., Tapan S., ERÇİN C. N., Acikel C., et al.
Annals of Hepatology , cilt.12, sa.4, ss.380-387, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis

Genc H., Dogru T., Celebi G., Tapan S., Kara M., ERÇİN C. N., et al.
Gulhane Medical Journal , cilt.55, sa.2, ss.84-88, 2013 (Scopus, TRDizin)

25. Efficacy of a Modified Sequential Therapy Including Bismuth Subcitrate as First-Line Therapy to Eradicate Helicobacter pylori in a Turkish Population

UYGUN A., Ozel A. M., Sivri B., Polat Z., Genç H., Sakin Y. S., et al.
Helicobacter , cilt.17, sa.6, ss.486-490, 2012 (SCI-Expanded, Scopus)

26. Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

Dogru T., Genc H., Tapan S., ERÇİN C. N., Ors F., Aslan F., et al.
Diabetes Research and Clinical Practice , cilt.96, sa.1, ss.47-52, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Visfatin and gallstone disease

Dogru T., Kara M., ERÇİN C. N., Meral C., Erdem G.
American Journal of Surgery , cilt.203, sa.3, ss.410, 2012 (SCI-Expanded, Scopus)

28. Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis

Genc H., Dogru T., Tapan S., Kara M., ERÇİN C. N., Aslan F., et al.
Scandinavian Journal of Gastroenterology , cilt.46, sa.11, ss.1355-1361, 2011 (SCI-Expanded, Scopus)

29. Non-invasive prediction of fibrosis in non-alcoholic fatty liver disease

Dogru T., Genc H., ERÇİN C. N., Tapan S.
Journal of Hepatology , cilt.55, sa.2, ss.498-499, 2011 (SCI-Expanded, Scopus)

30. Decreased small dense LDL levels in Gilbert's syndrome

Tapan S., KARADURMUŞ N., Dogru T., ERÇİN C. N., Tasci I., Bilgi C., et al.
Clinical Biochemistry , cilt.44, sa.4, ss.300-303, 2011 (SCI-Expanded, Scopus)

31. Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease

Kilciler G., Genc H., Tapan S., Ors F., Kara M., KARADURMUŞ N., et al.
Upsala Journal of Medical Sciences , cilt.115, sa.4, ss.253-259, 2010 (SCI-Expanded, Scopus)

32. Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease

Tapan S., Dogru T., Kara M., ERÇİN C. N., Kilciler G., Genc H., et al.
Scandinavian Journal of Clinical and Laboratory Investigation , cilt.70, sa.6, ss.399-403, 2010 (SCI-Expanded, Scopus)

33. The relationship of plasma adiponectin with liver fibrosis in morbid obesity

Dogru T., KARADURMUŞ N., Kilciler G., Tapan S., ERÇİN C. N.
Obesity Surgery , cilt.20, sa.10, ss.1462, 2010 (SCI-Expanded, Scopus)

34. Plasma apelin levels in subjects with nonalcoholic fatty liver disease

ERÇİN C. N., Dogru T., Tapan S., Kara M., HAYMANA C., KARADURMUŞ N., et al.
Metabolism: Clinical and Experimental , cilt.59, sa.7, ss.977-981, 2010 (SCI-Expanded, Scopus)

35. Plasma apelin and ADMA levels in patients with essential hypertension

Sonmez A., Celebi G., Erdem G., Tapan S., Genc H., Tasci I., et al.
Clinical and Experimental Hypertension , cilt.32, sa.3, ss.179-183, 2010 (SCI-Expanded, Scopus)

36. Non-alcoholic fatty liver disease and adipocytokines

Dogru T., ERÇİN C. N., Tasci I.
Liver International , cilt.30, sa.5, ss.771, 2010 (SCI-Expanded, Scopus)

37. Levels of soluble CD40 ligand and p-selectin in nonalcoholic fatty liver disease

ERÇİN C. N., Dogru T., Tapan S., KARSLIOĞLU Y., HAYMANA C., Kilic S., et al.
Digestive Diseases and Sciences , cilt.55, sa.4, ss.1128-1134, 2010 (SCI-Expanded, Scopus)

38. Retinol-binding protein 4 concentrations in nonalcoholic fatty liver disease

Dogru T., Kara M., ERÇİN C. N., Acikel C., Tapan S.
Journal of Clinical Gastroenterology , cilt.44, sa.3, ss.231-232, 2010 (SCI-Expanded, Scopus)

39. Elevated plasma levels of apelin in children with type 1 diabetes mellitus

Meral C., Tascilar E., KARADEMİR F., Tanju I. A., Cekmez F., Ipcioglu O. M., et al.
Journal of Pediatric Endocrinology and Metabolism , cilt.23, sa.5, ss.497-502, 2010 (SCI-Expanded, Scopus)

40. Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia

ERÇİN C. N., UYGUN A., Toros A. B., Kantarcioǧlu M., Kilciler G., Polat Z., et al.
Turkish Journal of Gastroenterology , cilt.21, sa.1, ss.12-16, 2010 (SCI-Expanded, Scopus, TRDizin)

41. Solitary Peutz-Jeghers-type hamartomatous polyp as a cause of recurrent acute pancreatitis

Kantarcioglu M., Kilciler G., Turan I., ERÇİN C. N., KARSLIOĞLU Y., Guvenc I., et al.
Endoscopy , cilt.41, sa.SUPPL. 2, 2009 (SCI-Expanded, Scopus)

42. Adipocytokine levels in nonalcoholic fatty liver disease

Dogru T., ERÇİN C. N., Tapan S., Kantarcioglu M., Kara M., Bagci S.
Hepatology , cilt.50, sa.1, ss.326-327, 2009 (SCI-Expanded, Scopus)

43. The hepatic apelin system: A new therapeutic target for liver disease

Dogru T., ERÇİN C. N., Erdem G., Kilciler G., Tapan S.
Hepatology , cilt.49, sa.3, ss.1055, 2009 (SCI-Expanded, Scopus)

44. Orlistat for overweight subjects with nonalcoholic steatohepatitis

Dogru T., ERÇİN C. N., Tasci I., Tapan S., Yesilova Z., UYGUN A.
Hepatology , cilt.49, sa.6, ss.2127, 2009 (SCI-Expanded, Scopus)

45. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?

Tapan S., Dogru T., Tasci I., ERÇİN C. N., ÖZGÜRTAŞ T., Erbil M. K.
Clinical Biochemistry , cilt.42, sa.9, ss.791-795, 2009 (SCI-Expanded, Scopus)

46. Insulin resistance in prediction of esophageal varices

Dogru T., ERÇİN C. N., Tapan S., Polat Z., Gulsen M., Bagci S.
Hepatology , cilt.49, sa.5, ss.1775-1776, 2009 (SCI-Expanded, Scopus)

47. Adipocytokine levels in chronic pancreatitis

ERÇİN C. N., Dogru T., Erdem G., Tasci I., Sonmez A., Tapan S.
Pancreas , cilt.38, sa.4, ss.470-471, 2009 (SCI-Expanded, Scopus)

48. Serum adipokine levels in the obese people

Tasci I., Dogru T., Erdem G., Tapan S., ERÇİN C. N., Sonmez A.
International Journal of Biological Sciences , cilt.5, sa.3, ss.286, 2009 (SCI-Expanded, Scopus)

49. Adiponectin levels in patients undergoing coronary stenting

Tapan S., Dogru T., Tasci I., ERÇİN C. N., Erbil M. K.
Clinical Biochemistry , cilt.42, sa.6, ss.544-545, 2009 (SCI-Expanded, Scopus)

50. NASH and cardiovascular biomarkers

ERÇİN C. N., Dogru T., Tasci I., Erdem G., Sonmez A., Tapan S.
Obesity , cilt.17, sa.4, ss.627, 2009 (SCI-Expanded, Scopus)

51. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients

Erdem G., ERÇİN C. N., Dogru T., Tasci I., Sonmez A.
Nutrition , cilt.25, sa.2, ss.240, 2009 (SCI-Expanded, Scopus)

52. Hepatic steatosis, visceral adiposity, insulin resistance, adiponectin, and inflammation

Tasci I., Erdem G., Sonmez A., Dogru T., ERÇİN C. N.
Metabolism: Clinical and Experimental , cilt.58, sa.1, ss.141, 2009 (SCI-Expanded, Scopus)

53. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis

ERÇİN C. N., Yesilova Z., KORKMAZ A., Ozcan A., Oktenli C., UYGUN A.
Digestive Diseases and Sciences , cilt.54, sa.1, ss.75-79, 2009 (SCI-Expanded, Scopus)

54. Sulfasalazine-induced hypersensitivity: A case report of DRESS syndrome

Yeşilova Z., Kantarcioǧlu M., ERÇİN C. N., Safalioǧlu M., Kilciler G., Koç E., et al.
Turkish Journal of Gastroenterology , cilt.20, sa.4, ss.298-299, 2009 (SCI-Expanded, Scopus, TRDizin)

55. Oxidative stress in extrahepatic cholestasis

ERÇİN C. N., Bagci S., Yesilova Z., Aydin A., Sayal A., Erdem G.
Anatolian Journal of Clinical Investigation , cilt.2, sa.4, ss.150-154, 2008 (Scopus)

56. Liver in rheumatoid diseases Romati̇zmal hastaliklarda karaciǧer

ERÇİN C. N., Erçin O.
Anatolian Journal of Clinical Investigation , cilt.2, sa.3, ss.135-140, 2008 (Scopus)

57. The effect of helicobacter pylori eradication therapy on dyspepsia and histopathologic score in patients with helicobacter pylori positive nonulcer dyspepsia

ERÇİN C. N., Yesilova Z., Ozcan A., Gulsen M., Erdem G.
Anatolian Journal of Clinical Investigation , cilt.2, sa.3, ss.118-122, 2008 (Scopus)

58. Nonalcoholic steatohepatitis is frequently accompanied by metabolic diseases

Dogru T., ERÇİN C. N., Erdem G., Tasci I., Sonmez A., Tapan S.
Hepatology , cilt.48, sa.5, ss.1728, 2008 (SCI-Expanded, Scopus)

59. The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus

Erdem G., Dogru T., Tasci I., Bozoglu E., Muhsiroglu O., Tapan S., et al.
Diabetes Research and Clinical Practice , cilt.82, sa.2, ss.214-218, 2008 (SCI-Expanded, Scopus)

60. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects

ERÇİN C. N., Dogru T., Tasci I., Erdem G., Sonmez A.
Obesity Surgery , cilt.18, sa.10, ss.1357, 2008 (SCI-Expanded, Scopus)

61. Therapeutic lifestyle change intervention in metabolic syndrome decreases plasma visfatin levels

Erdem G., Naharci M., DEMİRTAŞ A., ERÇİN C. N., Tapan S., Tasci I., et al.
Anatolian Journal of Clinical Investigation , cilt.2, sa.2, ss.58-62, 2008 (Scopus)

62. Adipokines and cytokines in non-alcoholic fatty liver disease

Tasci I., Dogru T., ERÇİN C. N., Erdem G., Sonmez A.
Alimentary Pharmacology and Therapeutics , cilt.28, sa.2, ss.266-267, 2008 (SCI-Expanded, Scopus)

63. Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome

Yesilova Z., SERDAR M. A., ERÇİN C. N., Gunay A., Kilciler G., Hasimi A., et al.
Journal of Gastroenterology and Hepatology (Australia) , cilt.23, sa.10, ss.1556-1560, 2008 (SCI-Expanded, Scopus)

64. Circulating von Willebrand factor levels in patients with prediabetes

Erdem G., Genç H., Tapan S., ERÇİN C. N., Taşçi I., Doǧru T., et al.
Turkiye Klinikleri Journal of Medical Sciences , cilt.28, sa.6, ss.822-827, 2008 (Scopus)

65. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

Dogru T., ERÇİN C. N., Erdem G., Sonmez A., Tapan S., Tasci I.
American Journal of Gastroenterology , cilt.103, sa.12, ss.3217-3218, 2008 (SCI-Expanded, Scopus)

66. Rosiglitazone for Nonalcoholic Steatohepatitis

Dogru T., ERÇİN C. N., Erdem G., Tapan S., Tasci I., Sonmez A.
Gastroenterology , cilt.135, sa.6, ss.2156, 2008 (SCI-Expanded, Scopus)

67. Levels of serologic markers of celiac disease in patients with reflux esophagitis

Bagci S., ERÇİN C. N., Yesilova Z., Ozcan A., Degertekin B., Dagalp K.
World Journal of Gastroenterology , cilt.12, sa.41, ss.6707-6710, 2006 (Scopus)

68. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease

Gulsen M., Yesilova Z., Bagci S., UYGUN A., Ozcan A., ERÇİN C. N., et al.
Journal of Gastroenterology and Hepatology (Australia) , cilt.20, sa.9, ss.1448-1455, 2005 (SCI-Expanded, Scopus)

69. Endoscopic diagnosis and treatment in patients with bile duct injury due to cholecystectomy Kolesi̇stektomi̇ye baǧli safra yolu yaralanmalarinda endoskopi̇k tani ve tedavi̇

Baǧci S., ERÇİN C. N., Tüzün A., Gülşen M., UYGUN A., Balkan M., et al.
Gulhane Medical Journal , cilt.44, sa.4, ss.415-422, 2002 (Scopus, TRDizin)
Kitaplar 1

1. Nutraceuticals for Non-alcoholic Fatty Liver Disease

Sonmez A., ERÇİN C. N., Cesur M., Dogru T.
Contemporary Cardiology, Springer International Publishing Ag, ss.141-165, 2021
Metrikler

Yayın

70

Yayın (WoS)

62

Yayın (Scopus)

70

H-İndeks (WoS)

19

Atıf (Scopus)

1133

H-İndeks (Scopus)

21

Tez Danışmanlığı

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER